The effect of letrozole vs clomiphene citrate for ovulation induction in patients of infertility with polycystic ovarian syndrome

Santosh S. Basarakod; Meenakshi Bharadwaj; Pruthvi Raj V.; Chaitra N.

doi:10.18203/2320-1770.ijrcog20232936

Authors

Santosh S. Basarakod Department of Obstetrics and Gynecology, Dr. BR Ambedkar Medical College and Hospital, Bengaluru, Karnataka, India
Meenakshi Bharadwaj Department of Obstetrics and Gynaecology, Armed Forces Medical College, Pune, Maharashtra, India
Pruthvi Raj V. Department of Obstetrics and Gynaecology, General Hospital, Jayanagar, Bengaluru, Karnataka, India
Chaitra N. Department of Obstetrics and Gynecology, Dr BR Ambedkar medical college and hospital, Bengaluru, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20232936

Keywords:

Clomiphene citrate, Infertility, Letrozole, PCOS

Abstract

Background: The overall prevalence of primary infertility in India is 3.9% to 16.8%. PCOS being a recognized cause of infertility, affects 8 to 13% of all reproductive-age women. Clomiphene citrate (CC) is most commonly used as first line drug for ovulation induction. CC is selective estrogen receptor modulator (SERM) and has adverse effect on cervical mucus and endometrial receptivity resulting in low pregnancy rates. Letrozole an aromatase inhibitor is considered as better alternative drug due to its benefits over CC. Thus, the aim of the present study is to assess the effect of letrozole and clomiphene citrate for ovulation induction in women with PCOS and compare the pregnancy rates.

Methods: This is a hospital based randomized controlled study conducted on 89 patients at Armed forces medical college in western Maharashtra from June 2019 to May 22. Women with infertility due to PCOS attending OPD/IPD who fulfilled the inclusion criteria were included in the study. The subjects were divided into two groups through computer generated randomization and Group A of 45 subjects received letrozole for ovulation induction while Group B with 44 subjects received clomiphene citrate (CC). Data was analyzed and comparison among the study groups was done with the help of unpaired t test or Mann-Whitney test.

Results: The number of mature follicles after treatment was significantly greater in clomiphene citrate group (1.59 ± 1.04) as compared to letrozole (1.02 ± 0.76). However, there was statistically significant greater mono ovulation with letrozole (55.2% vs 40.3%, p=0.03). After ovulation induction, the mean endometrial thickness was significantly greater in letrozole group as compared to CC (9.85±2.32 mm vs. 8.45±1.53 mm; p<0.05). Ovulation rate with letrozole was 42.5% vs 32.5% and pregnancy rate was letrozole 20% vs CC 7.5% which was statistically significant (p<0.05).

Conclusions: Letrozole is a better drug for ovulation induction in women with PCOS with an ovulatory cycles as pregnancy rates are higher and lesser chance of multiple pregnancy.

Metrics

Metrics Loading ...

References

Patel A, Sharma P, Narayan P, Binu V S, Dinesh N, Pai J. Prevalence and predictors of infertility – specific stress in women diagnosed with primary infertility: A clinic-based study. J Hum Reprod Sci. 2016;9(1):28-34.

Anwar S, Anwar A. Infertility: A review on causes, treatment and management. Womens Health Gynecol. 2016;5:2-5.

Strowitzki T. Advanced diagnosis of polycystic ovary syndrome—new prediction models with standard parameters. Fertility Steril. 2021;115(1):92-3.

Akre S, Sharma K, Chakole S, Wanjari MB. Recent advances in the management of polycystic ovary syndrome: a review article. Cureus. 2022;14(8):e27689.

Woo J, Scott RK. 18-18: Polycystic Ovary Syndrome. Published online. 2021:2020-2021.

Witchel SF, Oberfield SE, Pe~na AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545e1573.

Trent M, Gordon CM: Diagnosis and management of polycystic ovary syndrome in adolescents. Pediatrics. 2020;145(Supplement_2):S210-8.

Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM, et al. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):64-76.

Behnoud N, Farzaneh F, Ershadi S. The effect of clomiphene citrate versus letrozole on pregnancy rate in women with polycystic ovary syndrome: a randomized clinical trial. Crescent J Med Biolo Sci. 2019;6(3):335-40.

Tsiami AP, Goulis DG, Sotiriadis AI, Kolibianakis EM. Higher ovulation rate with letrozole as compared with clomiphene citrate in infertile women with polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens). 2021;20(3):449 – 61.

Huang S, Du X, Wang R, Li R, Wang H, Luo L, et al. Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs. Eur J Obstet Gynecol Reprod Biol. 2018;231:117–21.

Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019;111(3):571–578.e1.

Sakar MN, Oglak SC. Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome. Pak J Med Sci. 2020;36(7):1460-5.

Khakwani M, Parveen R, Yousaf S, Tareen AU. Efficacy of letrozole versus clomiphene citrate on ovulation induction in patients with polycystic ovarian syndrome. Pak J Med Sci. 2022;38(5):1155-8.

Bansal S, Goyal M, Sharma C, Shekar S. Letrozole versus clomiphene citrate for ovulation induction in anovulatory women with polycystic ovarian syndrome: A randomized controlled trial. Int J Gynaecol Obstet. 2021;152(#3):345-350.

Chakravorty R, Athwal A, Sur D, Saha R. A prospective, randomized trial comparing the effects of letrozole versus clomiphene citrate for induction ovulation and pregnancy rate in women with polycystic ovary syndrome. Fertil Sci Res. 2016;3(2):93-7.

Wang L, Qi H, Baker PN, Zhen Q, Zeng Q, Shi R, et al. Altered circulating inflammatory cytokines are associated with anovulatory polycystic ovary syndrome (PCOS) women resistant to clomiphene citrate treatment. Med Sci Monit. 2017;23:1083–9.

Elkhateeb RR, Mahran AE, Kamel HH. Long-term use of clomiphene citrate in induction of ovulation in PCO patients with clomiphene citrate resistance. J Gynecol Obstet Hum Reprod. 2017;46(7):575-7.

Wang L, Lv S, Li F, Bai E, Yang X. Letrozole versus clomiphene citrate and natural cycle: endometrial receptivity during implantation window in women with polycystic ovary syndrome. Front Endocrinol. 2021;11:532692.